Tyrphostins. 5. Potent Inhibitors of Platelet-Derived Growth Factor Receptor Tyrosine Kinase: Structure−Activity Relationships in Quinoxalines, Quinolines, and Indole Tyrphostins
作者:Aviv Gazit、Harald App、Gerald McMahon、Jefferey Chen、Alexander Levitzki、Frank D. Bohmer
DOI:10.1021/jm950727b
日期:1996.1.1
3-arylquinoxalines were prepared and tested for inhibition of platelet-derivedgrowthfactorreceptortyrosinekinase (PDGF-RTK) activity. The potency of the inhibitors was found to be quinoxalines > quinolines > indoles. Lipophilic groups (methyl, methoxy) in the 6 and 7 positions and phenyl at the 3 position of quinoxalines and quinolines were essential for potency, in contrast to the hydrophilic catechol
Hydrative syntheses of amides from alkynes catalyzed by an Au(I) complex containing pyridyl-functionalized NHC ligand
作者:Kuldeep Singh、Nilay Kumar Pal、Chirajyoti Guha、Jitendra K. Bera
DOI:10.1016/j.jorganchem.2019.02.011
日期:2019.4
the ligand scaffold is synthesized and its catalytic efficacy for the direct synthesis of the amide fromalkyne and sodium azide in acidic water is evaluated. Catalyst 1 readily converts a wide range of internal and terminalalkynes to the corresponding amides with low catalyst loading in TFA/DCE (2 mL, 1:1 v/v) at room temperature in short reaction time (2h) and without the use of Ag(I) additive. A
合成了在配体骨架上带有吡啶基的Au(I)-NHC络合物[L 1 AuBr](1),并评估了其在酸性水中由炔烃和叠氮化钠直接合成酰胺的催化效果。催化剂1在TFA / DCE(2 mL,1:1 v / v)中催化剂负载量低的情况下,很容易将各种内部和末端炔烃转化为相应的酰胺)在室温下以较短的反应时间(2 h)进行,并且不使用Ag(I)添加剂。不含吡啶基片段的相关催化剂显示出明显较低的活性,说明了启动子配体对水活化的作用。机理研究表明,炔烃最初会水合成酮,然后进行Schmidt反应生成酰胺。
One-step synthesis of 4-methyl-2-substituted quinazoline-3-oxides via polyphosphoric acid catalyzed acylation of electron-rich anilides with nitroethane
作者:Igor Yu Grishin、Alexander V. Aksenov、Nicolai A. Aksenov、Yuriy I. Grishin、Alexander V. Leontiev、Dmitrii A. Aksenov
DOI:10.1016/j.tet.2023.133784
日期:2024.1
A diverse set of 4-methyl-2-substituted quinazoline-3-oxides has been prepared usingpolyphosphoricacid both as a reaction medium and a Brønsted-acid catalyst. The reaction proceeds in a domino fashion via the formation of a corresponding oxime followed by exo-trig cyclization and elimination of a water molecule which leads, ultimately, to the target N-oxide heterocycles.
Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor
申请人:Sugen, Inc.
公开号:EP1000617A2
公开(公告)日:2000-05-17
The present invention concerns compounds which can inhibit platelet derived growth factor receptor (PDGF-R) activity, preferably such compounds also inhibit the activity of other members of the PDGF-R super family and are selective for members of the PDGF-R super family. The PDGF-R super family includes PDGF-R and PDGF-R related kinases Flt, and KDR. The featured compounds are active on cell cultures to reduce the activity of the PDGF-R and preferably one or more PDGF-R related kinases. An example of a featured compound, A10 (see Figure 1A), and its ability to inhibit growth of tumor cells in vivo is described below. Using the present application as guide, other compounds able to inhibit PDGF-R and preferably Flt and/or KDR can be obtained. Such compounds are preferably used to treat patients suffering from cell proliferative disorders characterized by inappropriate PDGF-R activity.
Dithiocarbamate and DBU-promoted amide bond formation under microwave condition
作者:Katari Naresh Kumar、Kintali Sreeramamurthy、Sadananda Palle、Khagga Mukkanti、Parthasarathi Das
DOI:10.1016/j.tetlet.2009.11.127
日期:2010.2
Dithiocarbamate and DBU-promoted amide bond formation under microwave condition has been reported. The versatility of this synthetic protocol has been demonstrated with various carboxylic acids and different dithiocarbamates. The products thus obtained have been characterized by mp, IR, H-1 NMR, and mass spectroscopy. (C) 2009 Elsevier Ltd. All rights reserved.